|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/343 | |
| A61P 25/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 3094322 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15701861.5 |
| Date of filing the European patent application | 2015-01-07 | |
| (97) | Date of publication of the European application | 2016-11-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/010410 |
| Date | 2015-01-07 |
| (87) | Number | WO 2015/108728 |
| Date | 2015-07-23 |
| (30) | Number | Date | Country code |
| 201461927465 P | 2014-01-14 | US | |
| 201414511669 | 2014-10-10 | US |
| (72) |
DRESSMAN, Marlene, Michelle, US
POLYMEROPOULOS, Mihael, H., US
BAROLDI, Paolo, US
|
| (73) |
Vanda Pharmaceuticals Inc.,
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037,
US
|
| (54) | ADMINISTRATION OF TASIMELTEON UNDER FASTED CONDITIONS |
| ADMINISTRATION OF TASIMELTEON UNDER FASTED CONDITIONS |